Enterprise Value
-3.57M
Cash
4.091M
Avg Qtr Burn
-2.654M
Short % of Float
29.56%
Insider Ownership
1.70%
Institutional Own.
2.99%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ADAIR (proprietary abuse-deterrent formulation of immediate-release) Details Attention deficit hyperactivity disorder | Phase 3 Update | |
GRI-0621 Details Lung disease, Idiopathic pulmonary fibrosis | Phase 2a Data readout | |
GRI-0803 Details Systemic lupus erythematosus, Autoimmune disease | IND Submission |